Clinical Trial Update: Study to Compare Efficacy and Safety of Cartistem and Microfracture in Patients With Knee Articular Cartilage Injury [Phase 3]

View source ↗

Summary

This Clinical Trial Update reports the completion of a Phase 3 study comparing Cartistem to Microfracture for knee articular cartilage injury.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Knee Articular Cartilage Injury
• Osteoarthritis of the Knee

Drugs mentioned

• CARTISTEM

Snippet

Sponsor: Medipost Co Ltd. | Conditions: Cartilage Injury, Osteoarthritis | Phase 3 | Status: COMPLETED